Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ALDH1L1 antisense RNA 1 (ALDH1L1-AS1) is a long non-coding RNA (lncRNA), transcribed in the antisense direction relative to the coding gene ALDH1L1; it is also known as SLC41A3-AS1 and related synonyms[4][9]. This RNA molecule is not translated into protein but is thought to play regulatory roles in gene expression, including possible involvement in cell proliferation, apoptosis, and migration[9]. Currently, ALDH1L1-AS1 is not considered a direct therapeutic target, receptor, enzyme, transporter, or traditional drug target; instead, it is studied as a regulatory RNA with potential roles in biology and cancer. Functional associations and disease links remain under active investigation.\n\n**Notes on ambiguity:**\nALDH1L1 antisense RNA 1 should not be confused with the protein-coding gene ALDH1L1, which is an enzyme with known tumor suppressor activity and several disease associations. The protein-coding ALDH1L1 has well-characterized functions, while ALDH1L1-AS1 is a distinct, non-coding RNA[4][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ALDH1L1 antisense RNA 1 (ALDH1L1-AS1).